4.7 Article

The Neuropathic Diabetic Foot Ulcer Microbiome Is Associated With Clinical Factors

期刊

DIABETES
卷 62, 期 3, 页码 923-930

出版社

AMER DIABETES ASSOC
DOI: 10.2337/db12-0771

关键词

-

资金

  1. National Institutes of Health (NIH),
  2. National Institute of Nursing Research [NINR R01 NR009448]
  3. National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIAMS R00 AR060873]
  4. NTH Intramural Research Program
  5. National Center for Research Resources
  6. National Center for Advancing Translational Sciences [UL1-RR-024979]

向作者/读者索取更多资源

Nonhealing diabetic foot ulcers (DFUs) are a common and costly complication of diabetes. Microbial burden, or bioburden, is believed to underlie delayed healing, although little is known of those clinical factors that may influence microbial load, diversity, and/or pathogenicity. We profiled the microbiomes of neuropathic nonischemic DFUs without clinical evidence of infection in 52 individuals using high-throughput sequencing of the bacterial 16S ribosomal RNA gene. Comparatively, wound cultures, the standard diagnostic in the clinic, vastly underrepresent microbial load, microbial diversity, and the presence of potential pathogens. DFU microbiomes were heterogeneous, even in our tightly restricted study population, but partitioned into three clusters distinguished primarily by dominant bacteria and diversity. Ulcer depth was associated with ulcer cluster, positively correlated with abundance of anaerobic bacteria, and negatively correlated with abundance of Staphylococcus. Ulcer duration was positively correlated with bacterial diversity, species richness, and relative abundance of Proteobacteria, but was negatively correlated with relative abundance of Staphylococcus. Finally, poor glycemic control was associated with ulcer cluster, with poorest median glycemic control concentrating to Staphylococcus-rich and Streptococcus-rich ulcer clusters. Analyses of microbial community membership and structure may provide the most useful metrics in prospective studies to delineate problematic bioburden from benign colonization that can then be used to chive clinical treatment. Diabetes 62:923-930,2013

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据